Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapy

Biotherapy. 1992;5(4):241-50. doi: 10.1007/BF02179041.

Abstract

We have previously reported that the antitumor effect of OK-432, a Streptococcal preparation, is markedly augmented when injected intratumorally together with fibrinogen (Cancer, 69: 636-642, 1992). In order to elucidate the mechanism of the antitumor effects, we established T cell clones from regional lymph nodes of colorectal cancer patients who received this local immunotherapy. By culture of lymph node lymphocytes, in the presence of IL-2 and OK-432, 4 clones of T cells were established from 4 patients treated by local immunotherapy. These clones had a helper T cell phenotype (CD3+, CD4+, CD8-, CD56-, WT31+) and were successfully maintained for several months. The cells strongly expressed CD25 when stimulated with OK-432 and exhibited a high level of cytotoxic activity in part explained by the increased expression of ICAM-1 and LFA-1, and the release of TNF beta. These results suggest that the CD4+ T cells play a role in the antitumor mechanism of local immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / cytology*
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Adhesion Molecules / physiology
  • Clone Cells
  • Colorectal Neoplasms / immunology*
  • Colorectal Neoplasms / therapy
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Immunotherapy*
  • Intercellular Adhesion Molecule-1
  • Lymph Nodes / cytology
  • Lymph Nodes / immunology
  • Lymphotoxin-alpha / physiology
  • Phenotype
  • Picibanil / therapeutic use
  • Stimulation, Chemical
  • T-Lymphocytes, Cytotoxic / cytology*
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Cell Adhesion Molecules
  • Lymphotoxin-alpha
  • Intercellular Adhesion Molecule-1
  • Picibanil